Synapse - Jamie Chaft

Search Within

Jamie Erin Chaft

Results (41)

YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics

Journal Article

Fan, P. D.; Narzisi, G.; Jayaprakash, A. D.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Yu, H. A.; Jordan, E. J.; Paik, P. K.; more...
Proceedings of the National Academy of Sciences of the United States of America (2018)

Fulltext@MSK | Save

Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing

Journal Article

Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies

Journal Article

Jordan, E. J.; Kim, H. R.; Arcila, M. E.; Barron, D.; Chakravarty, D.; Gao, J. J.; Chang, M. T.; Ni, A.; Kundra, R.; Jonsson, P.; more...
Cancer Discovery (2017)

Fulltext@MSK | Save

Impact of concurrent PIK3CA mutations on response to EGFR tyrosine kinase inhibition in EGFR-mutant lung cancers and on prognosis in oncogene-driven lung adenocarcinomas

Journal Article

Eng, J.; Woo, K. M.; Sima, C. S.; Plodkowski, A.; Hellmann, M. D.; Chaft, J. E.; Kris, M. G.; Arcila, M. E.; Ladanyi, M.; Drilon, A.
Journal of Thoracic Oncology (2015)

Fulltext@MSK | Save

Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma

Journal Article

Rekhtman, N.; Tafe, L. J.; Chaft, J. E.; Wang, L.; Arcila, M. E.; Colanta, A.; Moreira, A. L.; Zakowski, M. F.; Travis, W. D.; Sima, C. S.; more...
Modern Pathology (2013)

Fulltext@MSK | Save

EGFR exon 20 mutations: Molecular spectrum, incidence and clinicopathologic characteristics

Meeting Abstract

Liu, Y. C.; Nafa, K.; Chaft, J. E.; Rekhtman, N.; Reva, B.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Arcila, M. E.
Laboratory Investigation (2013)

Fulltext@MSK | Save

EGFR exon 20 mutations: Molecular spectrum, incidence and clinicopathologic characteristics

Meeting Abstract

Liu, Y. C.; Nafa, K.; Chaft, J. E.; Rekhtman, N.; Reva, B.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Arcila, M. E.
Modern Pathology (2013)

Fulltext@MSK | Save

EGFR exon 20 insertion mutations in lung adenocarcinomas: Prevalence, molecular heterogeneity, and clinicopathologic characteristics

Journal Article

Arcila, M. E.; Nafa, K.; Chaft, J. E.; Rekhtman, N.; Lau, C.; Reva, B. A.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
Molecular Cancer Therapeutics (2013)

Fulltext@MSK | Save

Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers

Journal Article

Varghese, A. M.; Sima, C. S.; Chaft, J. E.; Johnson, M. L.; Riely, G. J.; Ladanyi, M.; Kris, M. G.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas

Journal Article

Johnson, M. L.; Sima, C. S.; Chaft, J.; Paik, P. K.; Pao, W.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
Cancer (2013)

Fulltext@MSK | Save